MannKind prices USD 50 million private placement at USD 3.89 per share

• MannKind set a private placement expected to raise about USD 50 million in gross proceeds, with closing expected on or about July 24, 2026.
• Sale includes 10,440,838 common shares, with pre-funded warrants for up to 2,412,632 shares in lieu of stock for some investors.
• Pricing set at USD 3.89 per share, USD 3.88 per pre-funded warrant; warrants carry a USD 0.01 exercise price.
• Proceeds earmarked for general corporate purposes, including funding a USD 45 million CVR payment tied to Furoscix ReadyFlow FDA approval.
• Securities sold in an unregistered offering under Section 4(a)(2); resale registration statement to be filed with the SEC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MannKind Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607240635PRIMZONEFULLFEED9767569) on July 24, 2026, and is solely responsible for the information contained therein.